retatrutide ly3437943 parkinson's disease clinical trial Researchers evaluate a pipeline of trials targeting Incretin triple agonist retatrutide (LY3437943)
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20










-800x800.jpeg)















